JB Capital LLC Has $2.71 Million Stock Position in Kenvue Inc. (NYSE:KVUE)

JB Capital LLC grew its holdings in Kenvue Inc. (NYSE:KVUE) by 2.9% during the third quarter, Holdings Channel.com reports. The firm owned 117,301 shares of the company’s stock after acquiring an additional 3,320 shares during the quarter. JB Capital LLC’s holdings in Kenvue were worth $2,713,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Kenvue during the first quarter valued at approximately $1,050,000. Lorne Steinberg Wealth Management Inc. boosted its holdings in shares of Kenvue by 59.0% in the 2nd quarter. Lorne Steinberg Wealth Management Inc. now owns 154,690 shares of the company’s stock valued at $2,812,000 after buying an additional 57,375 shares during the last quarter. Kennon Green & Company LLC grew its stake in shares of Kenvue by 140.7% in the second quarter. Kennon Green & Company LLC now owns 159,106 shares of the company’s stock valued at $2,893,000 after buying an additional 93,008 shares in the last quarter. Czech National Bank grew its stake in shares of Kenvue by 20.3% in the second quarter. Czech National Bank now owns 364,886 shares of the company’s stock valued at $6,634,000 after buying an additional 61,635 shares in the last quarter. Finally, Crestwood Advisors Group LLC raised its position in Kenvue by 14.8% during the second quarter. Crestwood Advisors Group LLC now owns 1,537,348 shares of the company’s stock worth $27,950,000 after acquiring an additional 198,607 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on KVUE shares. Bank of America lifted their price objective on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. Citigroup lowered their price target on Kenvue from $21.00 to $20.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. Jefferies Financial Group started coverage on Kenvue in a research report on Tuesday, September 24th. They issued a “buy” rating and a $27.00 price objective for the company. JPMorgan Chase & Co. increased their price target on Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, UBS Group raised their price target on Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Kenvue has an average rating of “Hold” and a consensus price target of $22.64.

Kenvue Price Performance

Shares of Kenvue stock traded up $0.50 during midday trading on Thursday, hitting $23.00. 4,232,640 shares of the company traded hands, compared to its average volume of 18,035,377. The stock has a market cap of $44.05 billion, a price-to-earnings ratio of 38.79, a PEG ratio of 3.01 and a beta of 1.36. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.68 and a current ratio of 0.99. The firm’s fifty day moving average price is $22.59 and its 200-day moving average price is $20.49. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $23.57.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The company had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. During the same period in the prior year, the business earned $0.32 earnings per share. The company’s revenue for the quarter was down .3% compared to the same quarter last year. As a group, sell-side analysts forecast that Kenvue Inc. will post 1.08 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be issued a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a yield of 3.57%. Kenvue’s dividend payout ratio (DPR) is presently 141.38%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.